Induced Pluripotent Stem Cells Reduce Progression of Experimental Chronic Kidney Disease but Develop Wilms’ Tumors

Table 2

Histological changes and the effect of treatment with BMSC and iPS in 5/6 nephrectomized animals.

	CKD	BMSC	iPS
GS	23.6 ± 13^a	4 ± 3	1.8 ± 1
TID	78.2 ± 15	43 ± 29	62 ± 56

CKD: untreated chronic kidney disease; BMSC: rats treated with mesenchymal stem cells; iPS: rats treated with induced pluripotent stem cells; GS: glomerular sclerosis; TID: tubular damage. Data are expressed as means ± SD (^a versus BMSC and iPS).